Ambroxol is a medication commonly used as a mucolytic (helps break down mucus) and expectorant (helps clear airways). In this trial, it is being studied for a different purpose – to evaluate its potential benefits for people with Lewy body dementia. Research suggests that this medication might help protect brain cells and potentially slow down the progression of this type of dementia. While this is a new application for this well-known medication, it has an established safety profile from its traditional use in respiratory conditions.

Dementia with Lewy Bodies – A progressive brain condition characterized by the buildup of protein deposits called Lewy bodies in brain cells. The disease causes a decline in thinking, reasoning, and independent function. People with this condition experience changes in attention, alertness, and visual hallucinations. Memory problems may be less noticeable in the early stages compared to Alzheimer’s disease. Movement difficulties similar to Parkinson’s disease, such as rigid muscles and slow movement, often occur as the disease progresses. Sleep disorders and changes in behavior are also common features of this condition.